Appropriateness of Aspirin Use in Medical Outpatients
NCT03387384 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2018-12-19
Summary
This study aims to describe the demographic characteristics and current status of the aspirin use for primary and secondary prevention of cardiovascular diseases in a large, multicenter nationwide study
Conditions
- Primary Prevention of Cardiovascular Diseases
Interventions
- OTHER
-
Non-interventional study
Non-interventional study
Sponsors & Collaborators
-
Muğla Sıtkı Koçman University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-30
- Primary Completion
- 2019-06-30
- Completion
- 2019-07-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular Disease
NCT03757156 ·Status: UNKNOWN ·Phase: NA
-
Aspirin Dose and Atherosclerosis in Patients With Heart Disease
NCT00272337 ·Status: COMPLETED ·Phase: PHASE4
-
PRescriptiOn PattERns Of Oral Anticoagulants
NCT02366338 ·Status: COMPLETED
-
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
NCT05347069 ·Status: RECRUITING ·Phase: PHASE4
-
ASPIRIN Trial Belgium
NCT03464305 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users
NCT01814943 ·Status: COMPLETED
-
Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
NCT00272311 ·Status: COMPLETED ·Phase: PHASE4
-
Association of PeriOPerative Aspirin-ResisTance and CardioVascular Outcome
NCT04053894 ·Status: UNKNOWN
-
Perioperative Aspirin Usage Survey
NCT02561507 ·Status: TERMINATED
-
The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis
NCT02261025 ·Status: COMPLETED ·Phase: NA
-
Upper GI Symptoms In Patients Receiving Acetylsalicylic Acid/NSAIDs - NSAIDs Wave 2
NCT00691743 ·Status: COMPLETED
-
Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients
NCT01364779 ·Status: COMPLETED
-
Effect of Aspirin on Gut Microbiome
NCT02761486 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting
NCT00966485 ·Status: COMPLETED ·Phase: NA
-
A Healthy Female and Male Volunteers Aspirin Study
NCT01448031 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg
NCT01669824 ·Status: COMPLETED
-
Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study
NCT05247931 ·Status: UNKNOWN
-
Aspirin in Reducing Events in the Elderly
NCT01038583 ·Status: UNKNOWN
-
Timed Aspirin Chronobiome Study
NCT03590821 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Duration of Platelet Inhibition by Aspirin
NCT00671021 ·Status: COMPLETED
-
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension
NCT05056896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
NCT05718531 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting
NCT01276691 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Biochemical Markers to Determine the Acetylsalicylic Acid Chemopreventive Effect Through Antiplatelet Action
NCT02060396 ·Status: COMPLETED ·Phase: PHASE1
-
Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
NCT01709994 ·Status: UNKNOWN ·Phase: PHASE3